Jay - You are ultimately responsible for your money and researching what you invested in, learn from your losses and move on. Don't sit here blaming the ASX because you didn't realise it would take years to do an immunotherapy study.
- Forums
- ASX - By Stock
- AVR
- Ann: Admedus Releases Results of HSV-2 Phase IIa Study
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-186
-
- There are more pages in this discussion • 165 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$18.39 |
Change
-0.160(0.86%) |
Mkt cap ! $363.6M |
Open | High | Low | Value | Volume |
$18.80 | $19.15 | $18.33 | $153.5K | 8.273K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $18.21 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$18.39 | 317 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 308 | 18.200 |
1 | 250 | 18.010 |
2 | 2010 | 18.000 |
1 | 55 | 17.910 |
1 | 300 | 17.850 |
Price($) | Vol. | No. |
---|---|---|
18.470 | 890 | 2 |
18.500 | 90 | 1 |
18.540 | 18 | 2 |
18.600 | 35 | 1 |
19.000 | 9589 | 2 |
Last trade - 15.21pm 28/06/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online